Linguistic validation of the Japanese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

被引:0
|
作者
Miyaji, Tempei [1 ]
Iioka, Yukiko [2 ]
Iwase, Satoru [1 ]
Goto, Yasushi [3 ]
Tsuboi, Masahiro [4 ]
Yamamoto, Daigo [5 ]
Odagiri, Hiroki [6 ]
Tsubota, Yu [7 ]
Kawaguchi, Takashi [8 ]
Anzai, Natsumi [9 ]
Mitchell, Sandra A. [10 ]
Basch, Ethan [11 ]
Yamaguchi, Takuhiro [12 ]
机构
[1] Univ Tokyo, Tokyo, Tokyo, Japan
[2] St Lukes Coll Nursing, Tokyo, Japan
[3] Natl Canc Ctr, Tokyo, Japan
[4] Natl Canc Ctr, East Hosp, Chiba, Japan
[5] Kansai Med Univ, Takii Hosp, Osaka, Japan
[6] Natl Hirosaki Hosp, Aomori, Japan
[7] Kansai Med Univ, Osaka, Japan
[8] Tokyo Univ Pharm & Life Sci, Tokyo, Japan
[9] Tokyo Univ Pharm & Life Sci, Tokyo, Japan
[10] NCI, Rockville, MD USA
[11] Univ N Carolina, Chapel Hill, NC USA
[12] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
1037
引用
收藏
页码:78 / 78
页数:1
相关论文
共 50 条
  • [21] Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Becker, Claus
    Rogak, Lauren J.
    Schrag, Deborah
    Reeve, Bryce B.
    Spears, Patricia
    Smith, Mary Lou
    Gounder, Mrinal M.
    Mahoney, Michelle R.
    Schwartz, Gary K.
    Bennett, Antonia, V
    Mendoza, Tito R.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Bruner, Deborah Watkins
    Schwab, Gisela
    Atkinson, Thomas M.
    Thanarajasingam, Gita
    Bertagnolli, Monica M.
    Dueck, Amylou C.
    CLINICAL TRIALS, 2021, 18 (01) : 104 - 114
  • [22] DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)
    Basch, E.
    Reeve, B.
    Cleeland, C.
    Sloan, J.
    Schrag, D.
    Atkinson, T. M.
    Mendoza, T.
    Hay, J.
    Abernethy, A.
    Minasian, L.
    Kwitkowski, V
    Trentacosti, A. M.
    Burke, L.
    Sit, L.
    Bruner, D.
    VALUE IN HEALTH, 2010, 13 (07) : A274 - A275
  • [23] DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS ( PRO-CTCAE)
    Basch, E.
    Reeve, B.
    Cleeland, C.
    Sloan, J.
    Mendoza, T.
    Abernethy, A.
    Bruner, D.
    Hay, J.
    Atkinson, T.
    Sit, L.
    Minasian, L.
    O'Mara, A.
    Burke, L.
    Schrag, D.
    VALUE IN HEALTH, 2010, 13 (03) : A44 - A44
  • [24] Development of the Patient-Reported Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Reeve, Bryce
    Cleeland, Charles S.
    Sloan, Jeff A.
    Schrag, Deborah
    Atkinson, Thomas M.
    Mendoza, Tito R.
    Hay, Jennifer L.
    Abernethy, Amy P.
    Minasian, Lori
    Kwitkowski, Virginia
    Trentacosti, Ann Marie
    Burke, Laurie
    Sit, Laura
    Bruner, Deborah W.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 50 - 51
  • [25] Development of the patient-reported version of the common terminology criteria for adverse events (PRO-CTCAE)
    Basch, E. M.
    Reeve, B. B.
    Cleeland, C. S.
    Sloan, J. A.
    Mendoza, T. R.
    Abemethy, A. P.
    Bruner, D.
    Minasian, L. M.
    Burke, L. B.
    Schrag, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Validity and reliability of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
    Dueck, Amylou C.
    Mendoza, Tito R.
    Mitchell, Sandra A.
    Reeve, Bryce B.
    Castro, Kathleen M.
    Denicoff, Andrea
    O'Mara, Ann M.
    Rogak, Lauren J.
    Clauser, Steven B.
    Bryant, Donna M.
    Gillis, Theresa A.
    Bearden, James D.
    Siegel, Robert D.
    Harness, Jay K.
    Paul, Diane B.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Schrag, Deborah
    Minasian, Lori M.
    Basch, Ethan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Development of a composite scoring algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Basch, Ethan
    Becker, Claus
    Rogak, Lauren J.
    Schrag, Deborah
    Reeve, Bryce B.
    Spears, Patricia
    Smith, Mary Lou
    Gounder, Mrinal M.
    Mahoney, Michelle R.
    Schwartz, Gary K.
    Bennett, Antonia V.
    Mendoza, Tito R.
    Cleeland, Charles S.
    Sloan, Jeff A.
    Abernethy, Amy P.
    Bruner, Deborah Watkins
    Schwab, Gisela
    Atkinson, Thomas M.
    Thanarajasingam, Gita
    Bertagnolli, Monica M.
    Dueck, Amylou C.
    QUALITY OF LIFE RESEARCH, 2019, 28 : S43 - S44
  • [28] Linguistic Validation of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean
    Cho, Juhee
    Yoon, Junghee
    Kim, Youngha
    Oh, Dongryul
    Kim, Seok Jin
    Ahn, Jinseok
    Suh, Gee Young
    Nam, Seok Jin
    Mitchell, Sandra A.
    JOURNAL OF GLOBAL ONCOLOGY, 2019, 5
  • [29] Validation of the German Patient- Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
    Hagelstein, V.
    Ortland, I.
    Wilmer, A.
    Mitchell, S. A.
    Jaehde, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 6 - +
  • [30] Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (vol 1, pg 1051, 2015)
    Dueck, A. C.
    Mendoza, T. R.
    Mitchell, S. A.
    JAMA ONCOLOGY, 2016, 2 (01) : 146 - 146